المؤلفون: Lewis, K.D., Peris, K., Sekulic, A., Stratigos, A.J., Dunn, L., Eroglu, Z., Chang, A.L.S., Migden, M.R., Yoo, S.-Y., Mohan, K., Coates, E., Okoye, E., Bowler, T., Baurain, J.-F., Bechter, O., Hauschild, A., Butler, M.O., Hernandez-Aya, L., Licitra, L., Neves, R.I., Ruiz, E.S., Seebach, F., Lowy, I., Goncalves, P., Fury, M.G.

المساهمون: Regeneron Pharmaceuticals, Sanofi

المصدر: Annals of Oncology ; volume 35, issue 2, page 221-228 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.annonc.2023.10.123Test
https://api.elsevier.com/content/article/PII:S0923753423043296?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753423043296?httpAccept=text/plainTest

المؤلفون: Kennedy, OJ, Kicinski, M, Valpione, S, Gandini, S, Suciu, S, Blank, CU, Long, G, Atkinson, VG, Dalle, S, Haydon, AM, Meshcheryakov, A, Khattak, A, Carlino, MS, Sandhu, S, Larkin, J, Puig, S, Ascierto, PA, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, Di Giacomo, AM, van den Eertwegh, AJM, Grob, J-J, Gutzmer, R, Jamal, R, van Akkooi, ACJ, Robert, C, Eggermont, AMM, Lorigan, P, Mandala, M

العلاقة: pii: S0959-8049(22)00038-7; Kennedy, O. J., Kicinski, M., Valpione, S., Gandini, S., Suciu, S., Blank, C. U., Long, G., Atkinson, V. G., Dalle, S., Haydon, A. M., Meshcheryakov, A., Khattak, A., Carlino, M. S., Sandhu, S., Larkin, J., Puig, S., Ascierto, P. A., Rutkowski, P., Schadendorf, D. ,. Mandala, M. (2022). Prognostic and predictive value of beta-blockers in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma. EUROPEAN JOURNAL OF CANCER, 165, pp.97-112. https://doi.org/10.1016/j.ejca.2022.01.017Test.; http://hdl.handle.net/11343/322129Test

الإتاحة: https://doi.org/10.1016/j.ejca.2022.01.017Test
http://hdl.handle.net/11343/322129Test

المؤلفون: Eggermont, AMM, Kicinski, M, Blank, CU, Mandala, M, Long, GV, Atkinson, V, Dalle, S, Haydon, A, Khattak, A, Carlino, MS, Sandhu, S, Larkin, J, Puig, S, Ascierto, PA, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, Di Giacomo, AM, van den Eertwegh, AJM, Grob, J-J, Gutzmer, R, Jamal, R, Lorigan, PC, Krepler, C, Ibrahim, N, Marreaud, S, van Akkooi, A, Robert, C, Suciu, S

المساهمون: Larkin, James

مصطلحات موضوعية: Adult, Aged, Antibodies, Monoclonal, Humanized, Disease-Free Survival, Double-Blind Method, Female, Humans, Ipilimumab, Male, Melanoma, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Staging, Placebos, Proportional Hazards Models

جغرافية الموضوع: United States

وصف الملف: Print; 527; application/pdf

العلاقة: 2757843; JAMA Oncology, 2020, 6 (4), pp. 519 - 527; https://repository.icr.ac.uk/handle/internal/5286Test

الإتاحة: https://doi.org/10.1001/jamaoncol.2019.5570Test
https://repository.icr.ac.uk/handle/internal/5286Test

المؤلفون: Kennedy, OJ, Kicinski, M, Valpione, S, Gandini, S, Suciu, S, Blank, CU, Long, GV, Atkinson, VG, Dalle, S, Haydon, AM, Meshcheryakov, A, Khattak, A, Carlino, MS, Sandhu, S, Larkin, J, Puig, S, Ascierto, PA, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, Di Giacomo, AM, van den Eertwegh, AJM, Grob, J-J, Gutzmer, R, Jamal, R, van Akkooi, ACJ, Robert, C, Eggermont, AMM, Lorigan, P, Mandala, M

المساهمون: Larkin, James

مصطلحات موضوعية: Adrenergic beta-antagonists, Beta-blockers, Immunomodulation, Immunotherapy, Melanoma, Adjuvants, Immunologic, Antibodies, Monoclonal, Humanized, Humans, Neoplasm Staging, Prognosis, Skin Neoplasms, Tumor Microenvironment

جغرافية الموضوع: England

وصف الملف: Print-Electronic; 112; application/pdf

العلاقة: S0959-8049(22)00038-7; European Journal of Cancer, 2022, 165 pp. 97 - 112; https://repository.icr.ac.uk/handle/internal/5333Test

الإتاحة: https://doi.org/10.1016/j.ejca.2022.01.017Test
https://repository.icr.ac.uk/handle/internal/5333Test

المؤلفون: Sato, T., Ikeguchi, A.P., Nathan, P., Carvajal, R.D., Shoushtari, A.N., Gajewski, T.F., Hassel, J.C., Rioth, M., Leyvraz, S., Daniels, G.A., Hernandez-Aya, L., Johnson, D.B., Kim, K., Piulats Rodriguez, J.M., Cowey, C.L., Lockwood, S., Collins, L., Karakuzu, O., Sacco, J.J., Butler, M.O.

المصدر: Annals of Oncology ; volume 33, page S934-S935 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.annonc.2022.07.969Test
https://api.elsevier.com/content/article/PII:S0923753422028204?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753422028204?httpAccept=text/plainTest

المؤلفون: Rischin, D, Khushalani, N, Schmults, CD, Guminski, A, Chang, ALS, Lewis, KD, Lim, AM, Hernandez-Aya, L, Hughes, BGM, Schadendorf, D, Hauschild, A, Thai, AA, Stankevich, E, Booth, J, Yoo, S-Y, Li, S, Chen, Z, Okoye, E, Chen, C, Mastey, V, Sasane, M, Lowy, I, Fury, MG, Migden, MR

العلاقة: pii: jitc-2021-002757; Rischin, D., Khushalani, N., Schmults, C. D., Guminski, A., Chang, A. L. S., Lewis, K. D., Lim, A. M., Hernandez-Aya, L., Hughes, B. G. M., Schadendorf, D., Hauschild, A., Thai, A. A., Stankevich, E., Booth, J., Yoo, S. -Y., Li, S., Chen, Z., Okoye, E., Chen, C. ,. Migden, M. R. (2021). Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 9 (8), https://doi.org/10.1136/jitc-2021-002757Test.; http://hdl.handle.net/11343/287788Test

الإتاحة: https://doi.org/10.1136/jitc-2021-002757Test
http://hdl.handle.net/11343/287788Test

المؤلفون: Carvajal, R, Sato, T, Shoushtari, A, Sacco, J, Nathan, P, Orloff, M, Corrie, P, Steven, N, Evans, J, Infante, J, Sznol, M, Mulatero, C, Hamid, O, Hernandez-Aya, L, Little, N, McAlpine, C, Krige, D, Hassan, N, Patel, S, Hulstine, A, Coughlin, C, Middleton, M

العلاقة: https://ora.ox.ac.uk/objects/uuid:50a2c728-7ce9-4f2b-8bdd-68900b022db7Test; https://doi.org/10.1186/s40425-017-0289-3Test

الإتاحة: https://doi.org/10.1186/s40425-017-0289-3Test
https://ora.ox.ac.uk/objects/uuid:50a2c728-7ce9-4f2b-8bdd-68900b022db7Test

المؤلفون: Rischin, D, Migden, MR, Lim, AM, Schmults, CD, Khushalani, N, Hughes, BGM, Schadendorf, D, Dunn, LA, Hernandez-Aya, L, Chang, ALS, Modi, B, Hauschild, A, Ulrich, C, Eigentler, T, Stein, B, Pavlick, AC, Geiger, JL, Gutzmer, R, Alam, M, Okoye, E, Mathias, M, Jankovic, V, Stankevich, E, Booth, J, Li, S, Lowy, I, Fury, MG, Guminski, A

العلاقة: pii: jitc-2020-000775; Rischin, D., Migden, M. R., Lim, A. M., Schmults, C. D., Khushalani, N., Hughes, B. G. M., Schadendorf, D., Dunn, L. A., Hernandez-Aya, L., Chang, A. L. S., Modi, B., Hauschild, A., Ulrich, C., Eigentler, T., Stein, B., Pavlick, A. C., Geiger, J. L., Gutzmer, R., Alam, M. ,. Guminski, A. (2020). Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 8 (1), https://doi.org/10.1136/jitc-2020-000775Test.; http://hdl.handle.net/11343/244754Test

الإتاحة: https://doi.org/10.1136/jitc-2020-000775Test
http://hdl.handle.net/11343/244754Test

المؤلفون: Eggermont, AMM, Kicinski, M, Blank, CU, Mandala, M, Long, GV, Atkinson, V, Dalle, S, Haydon, A, Khattak, A, Carlino, MS, Sandhu, S, Larkin, J, Puig, S, Ascierto, PA, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, Di Giacomo, AM, van den Eertwegh, AJM, Grob, J-J, Gutzmer, R, Jamal, R, Lorigan, PC, Krepler, C, Ibrahim, N, Marreaud, S, van Akkooi, A, Robert, C, Suciu, S

العلاقة: pii: 2757843; Eggermont, A. M. M., Kicinski, M., Blank, C. U., Mandala, M., Long, G. V., Atkinson, V., Dalle, S., Haydon, A., Khattak, A., Carlino, M. S., Sandhu, S., Larkin, J., Puig, S., Ascierto, P. A., Rutkowski, P., Schadendorf, D., Koornstra, R., Hernandez-Aya, L., Di Giacomo, A. M. ,. Suciu, S. (2020). Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo A Secondary Analysis of a Randomized Clinical Trial. JAMA ONCOLOGY, 6 (4), pp.519-527. https://doi.org/10.1001/jamaoncol.2019.5570Test.; http://hdl.handle.net/11343/252306Test

الإتاحة: https://doi.org/10.1001/jamaoncol.2019.5570Test
http://hdl.handle.net/11343/252306Test

المؤلفون: Rischin, D, Khushalani, N, Schmults, C, Guminski, A, Chang, AL, Lewis, K, Lim, A, Hernandez-Aya, L, Hughes, B, Schadendorf, D, Hauschild, A, Stankevich, E, Booth, J, Yoo, S-Y, Chen, Z, Okoye, E, Lowy, I, Fury, M, Migden, M

العلاقة: Rischin, D., Khushalani, N., Schmults, C., Guminski, A., Chang, A. L., Lewis, K., Lim, A., Hernandez-Aya, L., Hughes, B., Schadendorf, D., Hauschild, A., Stankevich, E., Booth, J., Yoo, S. -Y., Chen, Z., Okoye, E., Lowy, I., Fury, M. & Migden, M. Phase 2 Study of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Longer Follow-Up. [Abstract]. SKIN The Journal of Cutaneous Medicine, 4 (6), pp.s124-s124. https://doi.org/10.25251/skin.4.supp.124Test.; http://hdl.handle.net/11343/288778Test

الإتاحة: https://doi.org/10.25251/skin.4.supp.124Test
http://hdl.handle.net/11343/288778Test